Bank of New York Mellon
QTTB icon

Bank of New York Mellon’s Q32 Bio QTTB Stock Holding History

Bank of New York Mellon’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-16,192
Closed -$26.7K – 4292
2025
Q1 		$26.7K Buy
16,192
+1,150
+8% +$3.1K ﹤0.01% 4079
2024
Q4 		$51.7K Hold
15,042
– – ﹤0.01% 4074
2024
Q3 		$671K Sell
15,042
-2,527
-14% -$92.9K ﹤0.01% 3353
2024
Q2 		$315K Buy
+17,569
New +$420K ﹤0.01% 3792
2024
Q1 		– Sell
-1,080
Closed -$11.8K – 4326
2023
Q4 		$11.8K Hold
1,080
– – ﹤0.01% 4263
2023
Q3 		$22.7K Hold
1,080
– – ﹤0.01% 4245
2023
Q2 		$17.2K Hold
1,080
– – ﹤0.01% 4302
2023
Q1 		$20K Hold
1,080
– – ﹤0.01% 4310
2022
Q4 		$24.5K Hold
1,080
– – ﹤0.01% 4329
2022
Q3 		$31K Hold
1,080
– – ﹤0.01% 4392
2022
Q2 		$38K Sell
1,080
-7,542
-87% -$257K ﹤0.01% 4400
2022
Q1 		$472K Sell
8,622
-297
-3% -$18.4K ﹤0.01% 3741
2021
Q4 		$584K Buy
8,919
+855
+11% +$83K ﹤0.01% 3702
2021
Q3 		$1.14M Buy
8,064
+668
+9% +$85.1K ﹤0.01% 3317
2021
Q2 		$968K Buy
7,396
+806
+12% +$101K ﹤0.01% 3443
2021
Q1 		$1.12M Sell
6,590
-79
-1% -$16.6K ﹤0.01% 3268
2020
Q4 		$1.35M Buy
6,669
+196
+3% +$37.9K ﹤0.01% 3069
2020
Q3 		$1.25M Sell
6,473
-28
-0.4% -$6.28K ﹤0.01% 2990
2020
Q2 		$1.78M Buy
6,501
+1,558
+32% +$415K ﹤0.01% 2753
2020
Q1 		$1.38M Sell
4,943
-238
-5% -$72.9K ﹤0.01% 2752
2019
Q4 		$1.93M Buy
5,181
+180
+4% +$51.6K ﹤0.01% 2837
2019
Q3 		$1.63M Buy
5,001
+178
+4% +$60.5K ﹤0.01% 2865
2019
Q2 		$1.7M Buy
4,823
+1,347
+39% +$529K ﹤0.01% 2884
2019
Q1 		$1.74M Buy
3,476
+224
+7% +$100K ﹤0.01% 2847
2018
Q4 		$1.31M Buy
3,252
+1,733
+114% +$655K ﹤0.01% 2951
2018
Q3 		$625K Hold
1,519
– – ﹤0.01% 3530
2018
Q2 		$558K Buy
+1,519
New +$544K ﹤0.01% 3588

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon's QTTB Position: Q2 2025 in Review

Bank of New York Mellon sold out of Q32 Bio (QTTB) in Q2 2025, closing a stake of 16,192 shares — an estimated $26.7K sold.

Bank of New York Mellon first reported a position in QTTB in Q2 2018 and held it in 27 quarters. The position peaked at $1.93M in Q4 2019. 61 funds tracked by Wall St. Rank hold QTTB as of Q2 2025.

  • Bank of New York Mellon reported no remaining Q32 Bio position as of Q2 2025 after selling out during the quarter.
  • Bank of New York Mellon sold 16,192 Q32 Bio shares in Q2 2025, an estimated $26.7K.
  • Bank of New York Mellon first reported a position in Q32 Bio in Q2 2018 and held it in 27 quarters.
  • Bank of New York Mellon's Q32 Bio position peaked at $1.93M in Q4 2019.
  • 61 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2025.

Based on Bank of New York Mellon's 13F filing for Q2 2025, filed 5 Aug 2025.